Non-Controlled, Non-Habit-Forming Medications for Insomnia

First-Line Recommendation: Ramelteon

The American Academy of Sleep Medicine recommends ramelteon 8 mg as the best non-controlled, non-habit-forming medication for insomnia, specifically for sleep onset difficulties 1
Ramelteon is a melatonin receptor agonist (MT1/MT2) that is not a DEA-scheduled controlled substance and has no abuse potential, according to the American Academy of Sleep Medicine 1, 2
Ramelteon is not classified as a controlled substance, making it appropriate for patients with substance use disorder history, as stated by the American Academy of Sleep Medicine 2
The standard dose of ramelteon is 8 mg taken 30 minutes before bedtime, and it is most effective for sleep onset insomnia rather than sleep maintenance, according to the American Academy of Sleep Medicine 1, 2

The American Academy of Sleep Medicine recommends doxepin 3-6 mg specifically for sleep maintenance insomnia, and it is not a controlled substance 1, 3
Doxepin should be used when the patient's primary complaint is waking during the night rather than difficulty falling asleep, as stated by the American Academy of Sleep Medicine 1
Only the 3-6 mg doses of doxepin are recommended for insomnia, as higher doses are used for depression, according to the American Academy of Sleep Medicine 1
Caution should be exercised when using doxepin in elderly patients due to anticholinergic effects, as recommended by the American Academy of Sleep Medicine 3

The American Academy of Sleep Medicine explicitly recommends against trazodone for insomnia, as the harms outweigh the benefits 1, 3
The American Academy of Sleep Medicine recommends against diphenhydramine, as tolerance develops after only 3-4 days and it has anticholinergic adverse effects, particularly in elderly patients 1, 4
The American Academy of Sleep Medicine recommends against melatonin supplements, as they lack evidence of efficacy for chronic insomnia 1

For sleep onset insomnia, the American Academy of Sleep Medicine recommends starting with ramelteon 8 mg, and if ineffective, considering controlled alternatives 1, 2
For sleep maintenance insomnia, the American Academy of Sleep Medicine recommends starting with doxepin 3-6 mg, and if ineffective, considering controlled alternatives 1, 3

The American Academy of Sleep Medicine advises against assuming over-the-counter antihistamines are safer than prescription hypnotics, as they have worse side effect profiles and rapid tolerance 4
The American Academy of Sleep Medicine recommends against prescribing trazodone for insomnia, despite its common off-label use, as guidelines explicitly recommend against it 1, 3
The American Academy of Sleep Medicine advises against using ramelteon for sleep maintenance problems, as its very short half-life makes it ineffective for this indication 2
The American Academy of Sleep Medicine recommends against continuing melatonin supplements, as evidence does not support efficacy 1